GNMXvsFMEDETF Comparison
VS
Corgi Genomics & Precision Medicine ETF (GNMX) belongs to the BioTech & Genomics segment. Fidelity Disruptive Medicine ETF (FMED) is part of the Multiple Trends segment. Both ETFs have the same top 3 sector exposures: and Healthcare. GNMX is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for FMED. Run a side-by-side ETF comparison of GNMX and FMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNMX vs FMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNMX FMED | +1.85%+5.01% | n/a+13.03% | n/a+4.92% | n/a+18.01% | n/a+13.15% | n/an/a |
| Flows | GNMX FMED | -- | --$17M | --$17M | --$14M | --$3M | -- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNMX FMED | n/a+22.48% | n/a+19.50% | n/a+18.58% | n/an/a |
| Max drawdown | GNMX FMED | n/a-5.92% | n/a-17.78% | n/a-21.42% | n/an/a |
| Max drawdown duration | GNMX FMED | n/a15d | n/a212d | n/a211d | n/an/a |
Trading data
GNMX | FMED | |
Last sale | ||
| Previous close 07/24/2026 | ||
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
GNMX | FMED | |
|---|---|---|
| Last price | – | – |
| 1D performance | – | – |
| AuM | $1.64 M | $46.16 M |
| E/R | 0.35% | 0.5% |
Characteristics
GNMX | FMED | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Corgi Funds | Fidelity |
| Benchmark | - | - |
| N° of holdings | 57 | 69 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 6, 2026 | June 12, 2023 |
| ESG | No | No |
Advertisement
Exposure
Countries
GNMX
USA
89.37%
Other
10.63%
FMED
USA
83.89%
Other
16.11%
Sectors
GNMX
Healthcare
98.21%
Other
1.79%
FMED
Healthcare
100%
Other
-0%
Advertisement
Diversification
GNMX
Total weight of top 15 holdings out of 15
53.1%
FMED
Total weight of top 15 holdings out of 15
41.87%
Top 15 holdings
Data as of June 30, 2026
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
FMED
Lifestance Health Group, Inc.
5.11%
10X Genomics, Inc.
3.56%
Danaher Corp.
3.29%
UCB SA
3.09%
Cogent Biosciences, Inc.
2.79%
Bio-Techne Corp.
2.76%
Moderna, Inc.
2.69%
Intuitive Surgical, Inc.
2.49%
argenx SE
2.43%
Alnylam Pharmaceuticals, Inc.
2.41%
Kymera Therapeutics, Inc.
2.36%
UnitedHealth Group, Inc.
2.27%
Thermo Fisher Scientific, Inc.
2.24%
Ascendis Pharma A/S
2.21%
Legend Biotech Corp.
2.17%
Frequently asked questions about GNMX and FMED
Which ETF is bigger: GNMX or FMED?
As of July 24, 2026, GNMX holds $1.64 M in assets under management (AUM), while FMED manages $46.16 M.
What sectors do the GNMX and FMED ETFs invest in?
GNMX leans toward sectors like Healthcare. Meanwhile, FMED focuses on Healthcare.
What are the top holdings of the GNMX ETF and FMED ETF?
GNMX top holdings include Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc.. FMED holds in its top three: Lifestance Health Group, Inc., 10X Genomics, Inc. and Danaher Corp..
Which ETF is more diversified: GNMX or FMED?
GNMX holds 57 securities with 53.1% of its assets in the top 15. FMED has 69 securities and a top 15 weight of 41.87%.
Advertisement
Advertisement
